| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |